Riverview Medical Center, part of Meridian CardioVascular Network, has received the Get With The Guidelines®-Heart Failure Silver Plus Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association/American College of Cardiology Foundation’s secondary prevention guidelines for patients with heart failure.
In this month’s release, find new embargoed research about return on investment in public health; cardiovascular risks for U.S. women; and effects of increased minimum wage on infant mortality.
Researchers at Johns Hopkins report that a type of lab-grown human nerve cells can partner with heart muscle cells to stimulate contractions. Because the heart-thumping nerve cells were derived from induced pluripotent stem (iPS) cells, the researchers believe the cells — known as sympathetic nerve cells — will allow them to grow nerve cells that replicate particular patients’ diseases of the nervous system.
Click here to go directly to the Diabetes News Source on Newswise
The Hospital of the University of Pennsylvania, Pennsylvania Hospital, Penn Presbyterian Medical Center, Chester County Hospital, and Lancaster General Hospital have received Get With The Guidelines®-Stroke Quality Achievement Awards from the American Heart Association/American Stroke Association
Women who put in long hours for the bulk of their careers may pay a steep price: life-threatening illnesses, including heart disease and cancer. Work weeks that averaged 60 hours or more over three decades appear to triple the risk of diabetes, cancer, heart trouble and arthritis for women, according to new research from The Ohio State University.
Researchers at the University of Missouri have found that Insulin-like Growth Factor-1 (IGF-1), a protein that is naturally found in high levels among adolescents, can help prevent arteries from clogging. They say that increasing atherosclerosis patients’ levels of the protein could reduce the amount of plaque buildup in their arteries, lowering their risk of heart disease.
Spirituality plays a central role in many aspects of African-American culture, and UAB School of Nursing postdoctoral scholar Deborah Ejem, Ph.D., will explore how significant a factor it is.
The Nancy and Harold Zirkin Heart & Vascular Hospital is opening in July on the campus of MedStar Washington Hospital Center, the Washington region’s highly regarded pioneer in cardiovascular care. The 164-bed state-of-the-art facility is the first and only heart and vascular hospital in the nation’s capital.
Ann Arbor, MI, June 14, 2016 - Coronary heart disease (CHD) is one of the leading causes of death in the United States. A new study evaluating recent trends in the prevalence of CHD in the U.S. population aged 40 years and older showed that CHD rates have decreased significantly, from 10.3% in 2001-2002 to 8.0% in 2011-2012. These results are reported in the American Journal of Preventive Medicine.
Aortic stenosis (AS), the narrowing of the aortic valve in the heart which causes restricted blood flow, is one of the most common and serious valve disease problems. For patients with one type of AS – low flow – transcatheter aortic valve replacement (TAVR), a minimally invasive procedure which corrects the damaged aortic valve, is often the best option for restoring the heart’s normal pumping function. Researchers from the Perelman School of Medicine at the University of Pennsylvania have examined this high-risk patient population to determine the cause of this persistent low flow AS and to evaluate their risk of dying during the year following the procedure. Their findings are detailed in a paper published in the Journal of the American Medical Association - Cardiology.
A batch of muffins, made with a special recipe formulated by the U.S. Department of Agriculture, yielded unexpected health benefits in patients with metabolic syndrome during a first-of-its-kind clinical study at the University of Maryland School of Medicine.
Congressman Larry Bucshon, MD (R-IN) was named “Legislator of the Year” by The Society of Thoracic Surgeons on Monday evening, in recognition for his extraordinary efforts promoting issues of importance to cardiothoracic surgeons.
Researchers at Mayo Clinic have developed an accurate way to measure a circulating factor, called GDF11, to better understand its potential impact on the aging process. They found that GDF11 levels do not decline with chronological age, but are associated with signs of advanced biological age, including chronic disease, frailty and greater operative risk in older adults with cardiovascular disease. Results appear today in Cell Metabolism.
Called Our Community, Our Health, the discussion will include a panel with UAMS experts in women’s heart health and an Arkansan with a family history of fatal heart disease. The event will begin with a reception at 4:30 p.m. followed by the town hall from 5-6 p.m. at the UAMS Donald W. Reynolds Institute on Aging, 629 Jack Stephens Drive, Room 1207. For those who prefer to view and participate online, login at http://bit.ly/1YbqKfM.
According to data from the large, multinational LEADER clinical trial, the glucose-lowering drug liraglutide safely and effectively decreases the overall risk of heart attack, stroke, or cardiovascular death, kidney disease, and death from all causes for people with type 2 diabetes.
Jersey Shore University Medical Center has one of the largest Cardiac Surgery Programs in the state and is the only hospital with these specialized capabilities in Monmouth and Ocean counties. Led by Richard Neibart, M.D., medical director of Meridian CardioVascular Network and chief of Cardiac Surgery, the program continues to expand with the recruitment of Kourosh T. Asgarian, D.O.
Babies born with heart defects live longer than ever thanks to advances in the diagnosis and treatment of congenital heart disease. Yet, despite substantial progress, many continue to face bleak odds, lifelong medication, multiple surgeries and progressive heart failure, often requiring a transplant.
Coronary or peripheral bypasses are the most frequently performed vascular operations. Although one million patients per year and around the world, undergo this intervention, its failure rate reaches 50%, because of poor vessel healing, leading to vessel graft occlusion. To improve the outcome of bypasses, researchers from the University of Geneva (UNIGE) work together with medical doctors from the Lausanne University Hospital (CHUV). They developed a gel containing microparticles –‘GeM’, enabling the controlled release of a drug inhibiting cellular over-proliferation. Administered locally, directly on the bypass graft during surgery, this preventive treatment will reduce the risk of obstruction reoccurrence. This research can be read in The Journal of Controlled Release.
Jianyi Zhang works to create tissue that can replace or protect damaged muscle after a heart attack. He and colleague offer perspectives on that in a paper in Science Translational Medicine, and he shares his plans to bioengineer heart tissue cell-by-cell.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right